ArticleFrontiers in pharmacology2022

Sodium-Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice.

Genlong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.